Suchergebnisse - "Rademacher, Michael"

PubPharm (8)

1

Normalization and cross-sectional validation of an extended Adverse Event Profile (E AEP) in a large cohort of patients with epilepsy

enthalten in: Seizure | 2024

von Helmstaedter, C. | Meschede, C. | Mastani, S. | +4

2

Focal Cortex Stimulation With a Novel Implantable Device and Antiseizure Outcomes in 2 Prospective Multicenter Single-Arm Trials

enthalten in: JAMA neurology | 2023

von Schulze-Bonhage, A. | Hirsch, M. | Knake, S. | +15

ErratumIn: JAMA Neurol. 2023 Nov 1;80(11):1253. - PMID 37782493

3

Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy : Results from two double-blind, randomized, placebo-controlled trials

enthalten in: Epilepsia open | 2022

von Rademacher, M. | Toledo, M. | Van Paesschen, W. | +9

4

Cognitive reawakening and improved quality of life achieved after discontinuing 16 years of anti-seizure treatment with topiramate

enthalten in: Neurocase | 2022

von Witt, J. | Rademacher, M. | von Wrede, R. | +2

5

Changes in cognition after introduction or withdrawal of zonisamide versus topiramate in epilepsy patients : A retrospective study using Bayes statistics

enthalten in: Epilepsia | 2020

von Meschede, C. | Witt, J. | Brömling, S. | +5

6

Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting

enthalten in: Seizure | 2018

von Meschede, C. | Witt, J. | Rademacher, M. | +3

7

Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam : A small phase IIIb, prospective, multicenter, open-label trial

enthalten in: Epilepsy & behavior : E&B | 2016

von Elger, C. | Rademacher, M. | Brandt, C. | +5

8

Bodyweight gain under pregabalin therapy in epilepsy : mitigation by counseling patients?

enthalten in: Seizure | 2008

von Hoppe, C. | Rademacher, M. | Hoffmann, J. | +2

1
[1]